| Towards a Non-Invasive Method for Early Detection of Testicular Neoplasia in Semen Samples by Identification of Fetal Germ Cell-Specific Markers |
|
|
|
|
|
| Thursday, 01 February 2007 | ||||
|
BERKELEY, CA (UroToday.com) - Testicular germ cell tumors (TGCTs) originate from a common precursor, carcinoma in situ (CIS).
The authors present an approach to detect CIS cells in the ejaculate using primordial germ cell/gonocyte as markers. Primordial germ cells were stained utilizing Immunocytological staining for AP-2[gamma] and/or OCT-3/4, NANOG or placental alkaline phosphatase (PLAP)]. Semen was stained from 294 infertile patients and 209 patient's testicular germ cell tumors. AP-2[gamma]-stained cells was detected in 50% of participants with CIS and in 33.9% of TGCT patients before treatment (non-seminomas: 56.6%, seminomas: 17.4%). OCT-3/4 results were similar to those of AP-2[gamma]. NANOG and PLAP were not suitable. The assay sensitivity for participants with CIS was 54.5% and greater than that for patients with tumors. Assay specificity was 93.6%, positive predictive value (PPV) 83.3% and negative predictive value (NPV) 60.3%. The authors concluded that this technique was Immunocytological semen analysis based on expression of fetal germ cell markers in exfoliated cells has auxiliary diagnostic value. However, a negative test does not exclude tumor. Editorial Comment C.E. Hoei-Hansen, E. Carlsen, N. Jorgensen, H. Leffers, N.E. Skakkebaek, and E. Rajpert-De Meyts Human Reproduction: 22(1):167-173, January 2007
Please log-in or register in order to submit comments. Powered by AkoComment! |
||||
| < Prev | Next > |
|---|
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2008 UroToday ® All Rights Reserved |










